Homocysteine and progression of coronary artery disease;Homocysteinemia we krwi a zaawansowanie choroby niedokrwiennej serca

Kardiologia Polska

Volumn 60, Issue 3, 2004, Pages 197-205

  Skibińska, Elzbieta ^a   Sawicki, Robert ^a   Lewczuk, Anna ^a   Prokop, Jolanta ^a   Musiał, Włodzimierz J ^a   Kowalska, Irina ^a   Mroczko, Barbara ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Atherosclerosis; Coronary artery disease; Diabetes; Homocysteine

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LIPID;

ADULT; AGE DISTRIBUTION; ARTICLE; ATHEROSCLEROSIS; CARBOHYDRATE ANALYSIS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONCENTRATION RESPONSE; CORONARY ARTERY DISEASE; CORONARY RISK; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK FACTOR; STATISTICAL SIGNIFICANCE;

EID: 1842479847     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. McCully K.S., Wilson R.B.: Homocysteine theory of atherosclerosis. Atherosclerosis 1975, 22, 215-27.
2. Naruszewicz M., Klinke M., Bukowska H. et al.: Elevated homocyst(e)ine increases ability of human aortic cells to oxidise LDL. Atherosclerosis 1997, 134, 13-14.
3. Hanratty C.G., McGrath L.T., McAuley D.F. et al.: Heart 2001, 85, 326-330.
4. Cleophas T.J., Hornstra N., van Hoogstraten B. et al.: Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis. Am. J. Cardiol. 2000, 86, 1005-9.
5. Nygard O., Nordrehaug J.E., Refsum H. et al.: Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 1997, 337, 230-236.
6. Eikelboom W., Lonn E., Genest J. et al.: Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Intern. Med. 1999, 131, 363-75.
7. Verhoef P., Hennekens C.H., Allen R.H. et al.: Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. Am. J. Cardiol. 1997, 79 799-801.
8. Hoogeven E.K., Kostense P.J., Jacobs C. et al.: Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes. 5-year follow-up of the Hoorn study. Circulation 2000, 101, 1506-1511.
9. Schnyder G., Roffi M., Pin R. et al.: Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N. Engl. J. Med. 2001, 345, 1593-1600.
10. Chambers J. C., Ueland P.M., Obeid O.A. et al.: Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000, 102, 2479-2483.
11. Thambyrajah J., Landray M.J., Jones H.J. et al.: A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. J. Am. Coll. Cardiol. 2001, 37, 1858-1863.
12. Bachórzewska-Gajewska H., Kowalska I., Prokop J. et al.: Zaburzenia metabolizmu wȩglowodanów u pacjentów z choroba̧ niedokrwienna̧ serca. Diabetologia Polska 1998, 5, 243-248.
13. Verhoef P., Kok F.J., Kruyssen D.A. et al.: Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 989-995.
14. Whincup P.H., Refsum H., Perry I.J. et al.: Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart 1999, 82, 448-454.
15. Chao C.L., Tsai H.H., Lee C.M. et al.: The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis. Atherosclerosis 1999, 147, 379-386.
16. Schnyder G., Pin R., Roffi M. et al.: Association of plasma homocysteine with the number of major coronary arteries severely narrowed. Am. J. Cardiol. 2001, 88, 1027-1030.
17. Anderson J.L., Horne B.D., Carlquist J.F. et al.: Effect of implementation of folic acid fortification of food on homocysteine concentrations in subjects with coronary artery disease. Am. J. Cardiol. 2002, 90, 536-539.
18. Genser D., Prachar H., Hauer R. et al.: Relation of homocysteine, vitamin B(12), and folate to coronary in-stent restenosis. Am. J. Cardiol. 2002, 89, 495-499.
19. Schnyder G., Flammer Y., Roffi M. et al.: Plasma homocysteine levels and late outcome after coronary angioplasty. J. Am. Coll. Cardiol. 2002, 40, 1769-1776.
20. Klerk M., Verhoef P., Clarke R. et al.: MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002, 288, 2023-2031.